Drug Shortage Report for CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE

Last updated on 2024-06-25 History
Report ID 224261
Drug Identification Number 02408813
Brand name CISATRACURIUM OMEGA MULTIDOSE
Common or Proper name CISATRACURIUM BESYLATE INJECTION
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) CISATRACURIUM
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 x 10mL vial / fiole
ATC code M03AC
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-08-01
Actual start date
Estimated end date Unknown
Actual end date 2024-06-25
Shortage status Avoided shortage
Updated date 2024-06-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2024-06-25 French Compare
v7 2024-06-25 English Compare
v6 2024-05-30 French Compare
v5 2024-05-30 English Compare
v4 2024-04-12 French Compare
v3 2024-04-12 English Compare
v2 2024-04-03 French Compare
v1 2024-04-03 English Compare

Showing 1 to 8 of 8